Molecular Targets and Therapies for Ampullary Cancer

Area of Science:

• Oncology
• Molecular Diagnostics
• Gastrointestinal Cancers

Background:

• Ampullary carcinomas are rare gastrointestinal malignancies with increasing incidence.
• These cancers exhibit molecular alterations that are crucial for guiding therapeutic strategies, particularly in cases where surgical resection is not feasible.
• Understanding these alterations is vital for personalized medicine approaches in ampullary cancer treatment.

Purpose of the Study:

• To review the current approaches for tissue acquisition and molecular testing in ampullary carcinomas.
• To discuss common and emerging molecular targets relevant to ampullary cancer therapy.
• To highlight the importance of molecular profiling for treatment selection in nonresectable ampullary cancers.

Main Methods:

• Review of literature on tissue acquisition and molecular testing methodologies for ampullary cancer.
• Discussion of established and novel molecular targets based on current research.
• Analysis of subtype-specific alterations in intestinal, pancreaticobiliary, and mixed subtypes.

Main Results:

• Next-generation sequencing is recommended for patients with unresectable ampullary carcinoma.
• Common molecular targets include HER2/ERBB2, HER3, tumor mutational burden, microsatellite instability, KRAS, and germline BRCA and ATM mutations.
• Molecular alterations can vary by ampullary carcinoma subtype, influencing therapeutic decisions.

Conclusions:

• Molecular profiling is essential for guiding therapy in ampullary carcinomas, especially in nonresectable settings.
• Comprehensive molecular testing, including next-generation sequencing, should be considered for all patients unable to undergo surgery.
• Identifying specific molecular alterations allows for targeted treatment strategies and improved patient outcomes.